Clinical Trial Update: A Study in People With Advanced Cancer (Solid Tumours) to Test Different Doses of BI 3810944 and to Find Out Whether it Helps [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating different doses of BI 3810944 in adults with advanced cancer, including melanoma, is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• BI 3810944

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Solid Tumours, Melanoma | Phase 1 | Status: RECRUITING